We recommend RBCTs in case of Hb < 7 g/dl according to current guidelines [8, 24] and the tolerance to anemia; in this regard, a higher Hb threshold could be used in patients "at risk" (e.g., elderly and/or with limited cardiovascular reserve because of pre-existing heart disease, etc.). The gene discussed is GSTM1; the disease is anemia.